150 related articles for article (PubMed ID: 22213127)
1. Gilbert syndrome redefined: a complex genetic haplotype influences the regulation of glucuronidation.
Ehmer U; Kalthoff S; Fakundiny B; Pabst B; Freiberg N; Naumann R; Manns MP; Strassburg CP
Hepatology; 2012 Jun; 55(6):1912-21. PubMed ID: 22213127
[TBL] [Abstract][Full Text] [Related]
2. Gilbert's disease and atazanavir: from phenotype to UDP-glucuronosyltransferase haplotype.
Lankisch TO; Moebius U; Wehmeier M; Behrens G; Manns MP; Schmidt RE; Strassburg CP
Hepatology; 2006 Nov; 44(5):1324-32. PubMed ID: 17058217
[TBL] [Abstract][Full Text] [Related]
3. Gilbert's syndrome and hyperbilirubinemia in protease inhibitor therapy--an extended haplotype of genetic variants increases risk in indinavir treatment.
Lankisch TO; Behrens G; Ehmer U; Möbius U; Rockstroh J; Wehmeier M; Kalthoff S; Freiberg N; Manns MP; Schmidt RE; Strassburg CP
J Hepatol; 2009 May; 50(5):1010-8. PubMed ID: 19303655
[TBL] [Abstract][Full Text] [Related]
4. A Gilbert syndrome-associated haplotype protects against fatty liver disease in humanized transgenic mice.
Landerer S; Kalthoff S; Paulusch S; Strassburg CP
Sci Rep; 2020 May; 10(1):8689. PubMed ID: 32457304
[TBL] [Abstract][Full Text] [Related]
5. Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates.
Udomuksorn W; Elliot DJ; Lewis BC; Mackenzie PI; Yoovathaworn K; Miners JO
Pharmacogenet Genomics; 2007 Dec; 17(12):1017-29. PubMed ID: 18004206
[TBL] [Abstract][Full Text] [Related]
6. Gilbert's Syndrome and irinotecan toxicity: combination with UDP-glucuronosyltransferase 1A7 variants increases risk.
Lankisch TO; Schulz C; Zwingers T; Erichsen TJ; Manns MP; Heinemann V; Strassburg CP
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):695-701. PubMed ID: 18349289
[TBL] [Abstract][Full Text] [Related]
7. Combined UGT1A1 and UGT1A7 variant alleles are associated with increased risk of Gilbert's syndrome in Taiwanese adults.
Teng HC; Huang MJ; Tang KS; Yang SS; Tseng CS; Huang CS
Clin Genet; 2007 Oct; 72(4):321-8. PubMed ID: 17850628
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms of bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese patients with Crigler-Najjar syndrome or Gilbert's syndrome as well as in healthy Japanese subjects.
Takeuchi K; Kobayashi Y; Tamaki S; Ishihara T; Maruo Y; Araki J; Mifuji R; Itani T; Kuroda M; Sato H; Kaito M; Adachi Y
J Gastroenterol Hepatol; 2004 Sep; 19(9):1023-8. PubMed ID: 15304120
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of a functional TATA box polymorphism of the UDP glucuronosyltransferase 1A7 gene.
Lankisch TO; Vogel A; Eilermann S; Fiebeler A; Krone B; Barut A; Manns MP; Strassburg CP
Mol Pharmacol; 2005 May; 67(5):1732-9. PubMed ID: 15716465
[TBL] [Abstract][Full Text] [Related]
10. UGT1A polymorphisms in a Swedish cohort and a human diversity panel, and the relation to bilirubin plasma levels in males and females.
Mercke Odeberg J; Andrade J; Holmberg K; Hoglund P; Malmqvist U; Odeberg J
Eur J Clin Pharmacol; 2006 Oct; 62(10):829-37. PubMed ID: 16909274
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics of Gilbert's syndrome.
Strassburg CP
Pharmacogenomics; 2008 Jun; 9(6):703-15. PubMed ID: 18518849
[TBL] [Abstract][Full Text] [Related]
12. Rapid allelic discrimination by TaqMan PCR for the detection of the Gilbert's syndrome marker UGT1A1*28.
Ehmer U; Lankisch TO; Erichsen TJ; Kalthoff S; Freiberg N; Wehmeier M; Manns MP; Strassburg CP
J Mol Diagn; 2008 Nov; 10(6):549-52. PubMed ID: 18832463
[TBL] [Abstract][Full Text] [Related]
13. Linkage disequilibrium of UGT1A1 *6 and UGT1A1 *28 in relation to UGT1A6 and UGT1A7 polymorphisms.
Urawa N; Kobayashi Y; Araki J; Sugimoto R; Iwasa M; Kaito M; Adachi Y
Oncol Rep; 2006 Oct; 16(4):801-6. PubMed ID: 16969497
[TBL] [Abstract][Full Text] [Related]
14. Gilbert-Meulengracht's syndrome and pharmacogenetics: is jaundice just the tip of the iceberg?
Strassburg CP
Drug Metab Rev; 2010 Feb; 42(1):168-81. PubMed ID: 20070246
[TBL] [Abstract][Full Text] [Related]
15. Polymorphic expression of the UDP-glucuronosyltransferase UGT1A gene locus in human gastric epithelium.
Strassburg CP; Nguyen N; Manns MP; Tukey RH
Mol Pharmacol; 1998 Oct; 54(4):647-54. PubMed ID: 9765507
[TBL] [Abstract][Full Text] [Related]
16. Genetic variants of UDP-glucuronosyltransferase 1A genes are associated with disease presentation and outcome in primary sclerosing cholangitis.
Weismüller TJ; Zhou T; Kalthoff S; Lenzen H; Manns MP; Strassburg CP
Liver Int; 2020 Jul; 40(7):1645-1654. PubMed ID: 32378294
[TBL] [Abstract][Full Text] [Related]
17. UGT1A1, UGT1A6 and UGT1A7 genetic analysis: repercussion for irinotecan pharmacogenetics in the São Miguel Island Population (Azores, Portugal).
Pacheco PR; Brilhante MJ; Ballart C; Sigalat F; Polena H; Cabral R; Branco CC; Mota-Vieira L
Mol Diagn Ther; 2009; 13(4):261-8. PubMed ID: 19712005
[TBL] [Abstract][Full Text] [Related]
18. The UDP-glucuronosyltransferase (UGT) 1A polymorphism c.2042C>G (rs8330) is associated with increased human liver acetaminophen glucuronidation, increased UGT1A exon 5a/5b splice variant mRNA ratio, and decreased risk of unintentional acetaminophen-induced acute liver failure.
Court MH; Freytsis M; Wang X; Peter I; Guillemette C; Hazarika S; Duan SX; Greenblatt DJ; Lee WM;
J Pharmacol Exp Ther; 2013 May; 345(2):297-307. PubMed ID: 23408116
[TBL] [Abstract][Full Text] [Related]
19. UGT1A1 dysfunction increases liver burden and aggravates hepatocyte damage caused by long-term bilirubin metabolism disorder.
Liu D; Yu Q; Li Z; Zhang L; Hu M; Wang C; Liu Z
Biochem Pharmacol; 2021 Aug; 190():114592. PubMed ID: 33961837
[TBL] [Abstract][Full Text] [Related]
20. Predictive role of the UGT1A1, UGT1A7, and UGT1A9 genetic variants and their haplotypes on the outcome of metastatic colorectal cancer patients treated with fluorouracil, leucovorin, and irinotecan.
Cecchin E; Innocenti F; D'Andrea M; Corona G; De Mattia E; Biason P; Buonadonna A; Toffoli G
J Clin Oncol; 2009 May; 27(15):2457-65. PubMed ID: 19364970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
